{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:54:45Z","timestamp":1773978885383,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T00:00:00Z","timestamp":1275609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2334-10-152","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T02:13:50Z","timestamp":1275704030000},"source":"Crossref","is-referenced-by-count":27,"title":["Statins in Candidemia: clinical outcomes from a matched cohort study"],"prefix":"10.1186","volume":"10","author":[{"given":"Graeme N","family":"Forrest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M","family":"Kopack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli N","family":"Perencevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,4]]},"reference":[{"key":"1132_CR1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003, 37: 1172-1177. 10.1086\/378745.","journal-title":"Clin Infect Dis"},{"key":"1132_CR2","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","volume":"39","author":"MA Pfaller","year":"2001","unstructured":"Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA: International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol. 2001, 39: 3254-3259. 10.1128\/JCM.39.9.3254-3259.2001.","journal-title":"J Clin Microbiol"},{"key":"1132_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/504810","volume":"43","author":"KW Garey","year":"2006","unstructured":"Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006, 43: 25-31. 10.1086\/504810.","journal-title":"Clin Infect Dis"},{"key":"1132_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ijantimicag.2007.01.001","volume":"29","author":"KW Garey","year":"2007","unstructured":"Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ: Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. Int J Antimicrob Agents. 2007, 29: 557-562. 10.1016\/j.ijantimicag.2007.01.001.","journal-title":"Int J Antimicrob Agents"},{"key":"1132_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.297.13.1455","volume":"297","author":"R Gupta","year":"2007","unstructured":"Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR: Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA. 2007, 297: 1455-1464. 10.1001\/jama.297.13.1455.","journal-title":"JAMA"},{"key":"1132_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/bmj.38992.565972.7C","volume":"333","author":"SR Majumdar","year":"2006","unstructured":"Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ: Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ. 2006, 333: 999-10.1136\/bmj.38992.565972.7C.","journal-title":"BMJ"},{"key":"1132_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1378\/chest.06-1997","volume":"131","author":"FJ Frost","year":"2007","unstructured":"Frost FJ, Petersen H, Tollestrup K, Skipper B: Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest. 2007, 131: 1006-1012. 10.1378\/chest.06-1997.","journal-title":"Chest"},{"key":"1132_CR8","volume-title":"Recent Pat Antiinfect Drug Discov","author":"GM Bearman","year":"2010","unstructured":"Bearman GM, Shankaran S, Elam K: Treatment of Severe Cases of Pandemic (H1N1) 2009 Influenza: Review of Antivirals and Adjuvant Therapy. Recent Pat Antiinfect Drug Discov. 2010,"},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1161\/01.CIR.0000138932.17956.F1","volume":"110","author":"Y Almog","year":"2004","unstructured":"Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A: Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004, 110: 880-885. 10.1161\/01.CIR.0000138932.17956.F1.","journal-title":"Circulation"},{"key":"1132_CR10","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1172\/JCI119812","volume":"100","author":"K Pahan","year":"1997","unstructured":"Pahan K, Sheikh FG, Namboodiri AM, Singh I: Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest. 1997, 100: 2671-2679. 10.1172\/JCI119812.","journal-title":"J Clin Invest"},{"key":"1132_CR11","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/01.ATV.19.12.2894","volume":"19","author":"D Pruefer","year":"1999","unstructured":"Pruefer D, Scalia R, Lefer AM: Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol. 1999, 19: 2894-2900.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1132_CR12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00134-009-1429-0","volume":"35","author":"V Novack","year":"2009","unstructured":"Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y: The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med. 2009, 35: 1255-1260. 10.1007\/s00134-009-1429-0.","journal-title":"Intensive Care Med"},{"key":"1132_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1574-6968.2006.00370.x","volume":"262","author":"IG Macreadie","year":"2006","unstructured":"Macreadie IG, Johnson G, Schlosser T, Macreadie PI: Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS Microbiol Lett. 2006, 262: 9-13. 10.1111\/j.1574-6968.2006.00370.x.","journal-title":"FEMS Microbiol Lett"},{"key":"1132_CR14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.bmcl.2005.10.101","volume":"16","author":"P Macreadie","year":"2006","unstructured":"Macreadie P, Avery T, Greatrex B, Taylor D, Macreadie I: Novel endoperoxides: synthesis and activity against Candida species. Bioorg Med Chem Lett. 2006, 16: 920-922. 10.1016\/j.bmcl.2005.10.101.","journal-title":"Bioorg Med Chem Lett"},{"key":"1132_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1567-1364.2006.00194.x","volume":"7","author":"C Westermeyer","year":"2007","unstructured":"Westermeyer C, Macreadie IG: Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata. FEMS Yeast Res. 2007, 7: 436-441. 10.1111\/j.1567-1364.2006.00194.x.","journal-title":"FEMS Yeast Res"},{"key":"1132_CR16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1042\/BST0351529","volume":"35","author":"K Wikhe","year":"2007","unstructured":"Wikhe K, Westermeyer C, Macreadie IG: Biological consequences of statins in Candida species and possible implications for human health. Biochem Soc Trans. 2007, 35: 1529-1532. 10.1042\/BST0351529.","journal-title":"Biochem Soc Trans"},{"key":"1132_CR17","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992, 101: 1644-1655. 10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2407-4-94","volume":"4","author":"WH Hall","year":"2004","unstructured":"Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S: An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer. 2004, 4: 94-10.1186\/1471-2407-4-94.","journal-title":"BMC Cancer"},{"key":"1132_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhin.2005.02.009","volume":"61","author":"M Weinberger","year":"2005","unstructured":"Weinberger M, Leibovici L, Perez S, Samra Z, Ostfeld I, Levi I, Bash E, Turner D, Goldschmied-Reouven A, Regev-Yochay G, Pitlik SD, Keller N: Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect. 2005, 61: 146-154. 10.1016\/j.jhin.2005.02.009.","journal-title":"J Hosp Infect"},{"key":"1132_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1567-1364.2006.00194.x","volume":"7","author":"C Westermeyer","year":"2007","unstructured":"Westermeyer C, Macreadie IG: Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata. FEMS Yeast Res. 2007, 7: 436-441. 10.1111\/j.1567-1364.2006.00194.x.","journal-title":"FEMS Yeast Res"},{"key":"1132_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1099\/0022-1317-51-2-105","volume":"51","author":"JD Nash","year":"2002","unstructured":"Nash JD, Burgess DS, Talbert RL: Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans. J Med Microbiol. 2002, 51: 105-109. 10.1016\/S0167-7012(02)00059-3.","journal-title":"J Med Microbiol"},{"key":"1132_CR22","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1086\/323334","volume":"33","author":"AP Liappis","year":"2001","unstructured":"Liappis AP, Kan VL, Rochester CG, Simon GL: The effect of statins on mortality in patients with bacteremia. Clin Infect Dis. 2001, 33: 1352-1357. 10.1086\/323334.","journal-title":"Clin Infect Dis"},{"key":"1132_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(06)68041-0","volume":"367","author":"DG Hackam","year":"2006","unstructured":"Hackam DG, Mamdani M, Li P, Redelmeier DA: Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006, 367: 413-418. 10.1016\/S0140-6736(06)68041-0.","journal-title":"Lancet"},{"key":"1132_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1592\/phco.27.1.20","volume":"27","author":"CP Martin","year":"2007","unstructured":"Martin CP, Talbert RL, Burgess DS, Peters JI: Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation. Pharmacotherapy. 2007, 27: 20-26. 10.1592\/phco.27.1.20.","journal-title":"Pharmacotherapy"},{"key":"1132_CR25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1086\/339763","volume":"34","author":"T Stefanec","year":"2002","unstructured":"Stefanec T: The effects of statins on mortality rates among bacteremic patients. Clin Infect Dis. 2002, 34: 1158-10.1086\/339763.","journal-title":"Clin Infect Dis"},{"key":"1132_CR26","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1001\/archinte.168.19.2067","volume":"168","author":"K Haldar","year":"2008","unstructured":"Haldar K: Targeting the host to control an infection disorder. Arch Intern Med. 2008, 168: 2067-2068. 10.1001\/archinte.168.19.2067.","journal-title":"Arch Intern Med"},{"key":"1132_CR27","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1001\/archinte.168.19.2081","volume":"168","author":"RW Thomsen","year":"2008","unstructured":"Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT: Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med. 2008, 168: 2081-2087. 10.1001\/archinte.168.19.2081.","journal-title":"Arch Intern Med"},{"key":"1132_CR28","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/cc8902","volume":"14","author":"S Christensen","year":"2010","unstructured":"Christensen S, Thomsen RW, Johansen MB, Pedersen L, Jensen R, Larsen KM, Larsson A, Tonnesen E, Sorensen HT: Preadmission statin use and one-year mortality among patients in intensive care - A cohort study. Crit Care. 2010, 14: R29-10.1186\/cc8902.","journal-title":"Crit Care"},{"key":"1132_CR29","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s00134-006-0246-y","volume":"32","author":"H Schmidt","year":"2006","unstructured":"Schmidt H, Hennen R, Keller A, Russ M, Muller-Werdan U, Werdan K, Buerke M: Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med. 2006, 32: 1248-1251. 10.1007\/s00134-006-0246-y.","journal-title":"Intensive Care Med"},{"key":"1132_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00134-008-1358-3","volume":"35","author":"PS Kruger","year":"2009","unstructured":"Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M: A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med. 2009, 35: 717-721. 10.1007\/s00134-008-1358-3.","journal-title":"Intensive Care Med"},{"key":"1132_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00134-005-2743-9","volume":"32","author":"R Fernandez","year":"2006","unstructured":"Fernandez R, De PV, Artigas A: Statin therapy prior to ICU admission: protection against infection or a severity marker?. Intensive Care Med. 2006, 32: 160-164. 10.1007\/s00134-005-2743-9.","journal-title":"Intensive Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T02:42:14Z","timestamp":1548124934000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-152","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,4]]},"article-number":"152"}}